These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17393062)

  • 21. The origin of mammalian plasma amine oxidases.
    Schwelberger HG
    J Neural Transm (Vienna); 2007; 114(6):757-62. PubMed ID: 17385066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells.
    Peng Y; Wang J; Zhang M; Niu P; Yang M; Yang Y; Zhao Y
    PLoS One; 2016; 11(4):e0152758. PubMed ID: 27043821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
    Yraola F; García-Vicente S; Fernandez-Recio J; Albericio F; Zorzano A; Marti L; Royo M
    J Med Chem; 2006 Oct; 49(21):6197-208. PubMed ID: 17034126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
    Schilter HC; Collison A; Russo RC; Foot JS; Yow TT; Vieira AT; Tavares LD; Mattes J; Teixeira MM; Jarolimek W
    Respir Res; 2015 Mar; 16(1):42. PubMed ID: 25889951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.
    Sun P; Esteban G; Inokuchi T; Marco-Contelles J; Weksler BB; Romero IA; Couraud PO; Unzeta M; Solé M
    Br J Pharmacol; 2015 Nov; 172(22):5390-402. PubMed ID: 26362823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
    Bono P; Salmi M; Smith DJ; Jalkanen S
    J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
    Unzeta M; Hernàndez-Guillamon M; Sun P; Solé M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.
    Martelius T; Salmi M; Wu H; Bruggeman C; Höckerstedt K; Jalkanen S; Lautenschlager I
    Am J Pathol; 2000 Oct; 157(4):1229-37. PubMed ID: 11021827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of L-lysine and soluble elastin with the semicarbazide-sensitive amine oxidase in the context of its vascular-adhesion and tissue maturation functions.
    Olivieri A; O'Sullivan J; Fortuny LR; Vives IL; Tipton KF
    Biochim Biophys Acta; 2010 Apr; 1804(4):941-7. PubMed ID: 20079884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystallization of a truncated soluble human semicarbazide-sensitive amine oxidase.
    Jakobsson E; Nilsson J; Källström U; Ogg D; Kleywegt GJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Mar; 61(Pt 3):274-8. PubMed ID: 16511016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans.
    Salmi M; Jalkanen S
    Blood; 2006 Sep; 108(5):1555-61. PubMed ID: 16556889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
    Hernandez-Guillamon M; Solé M; Delgado P; García-Bonilla L; Giralt D; Boada C; Penalba A; García S; Flores A; Ribó M; Alvarez-Sabin J; Ortega-Aznar A; Unzeta M; Montaner J
    Cerebrovasc Dis; 2012; 33(1):55-63. PubMed ID: 22133888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular adhesion protein-1 in human ischaemic stroke.
    Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of serum and tissue levels of VAP-1 in colorectal cancer.
    Ward ST; Weston CJ; Shepherd EL; Hejmadi R; Ismail T; Adams DH
    BMC Cancer; 2016 Feb; 16():154. PubMed ID: 26912327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and characterization of the human alpha 2B-adrenoceptor in a vascular smooth muscle cell line.
    Huhtinen A; Scheinin M
    Eur J Pharmacol; 2008 Jun; 587(1-3):48-56. PubMed ID: 18456256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors.
    Nurminen EM; Pihlavisto M; Lázár L; Pentikäinen U; Fülöp F; Pentikäinen OT
    J Med Chem; 2011 Apr; 54(7):2143-54. PubMed ID: 21405023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects.
    Li HY; Lin MS; Wei JN; Hung CS; Chiang FT; Lin CH; Hsu HC; Su CY; Wu MY; Smith DJ; Vainio J; Chen MF; Chuang LM
    Clin Chim Acta; 2009 May; 403(1-2):97-101. PubMed ID: 19361461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
    Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
    J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.
    Salmi M; Jalkanen S
    Antioxid Redox Signal; 2019 Jan; 30(3):314-332. PubMed ID: 29065711
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of two imidazole binding sites and key residues for substrate specificity in human primary amine oxidase AOC3.
    Elovaara H; Kidron H; Parkash V; Nymalm Y; Bligt E; Ollikka P; Smith DJ; Pihlavisto M; Salmi M; Jalkanen S; Salminen TA
    Biochemistry; 2011 Jun; 50(24):5507-20. PubMed ID: 21585208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.